Structural and Functional Characterization of Falcipain-2, a Hemoglobinase from the Malarial Parasite Plasmodium falciparum*
暂无分享,去创建一个
Xu Shen | Rolf Hilgenfeld | Hualiang Jiang | Hualiang Jiang | Xu Shen | R. Hilgenfeld | Maria Wecke | Li-li Chen | T. Hogg | C. Schmidt | Lili Chen | K. Nagarajan | Christian L Schmidt | Tanis Hogg | Krishna Nagarajan | Saskia Herzberg | Maria Wecke | Christoph Blohmke | C. Blohmke | S. Herzberg | Christoph J Blohmke
[1] J. McKerrow,et al. Cysteine Protease Inhibitors Cure an Experimental Trypanosoma cruzi Infection , 1998, Journal of Experimental Medicine.
[2] P. Rosenthal,et al. Plasmodium falciparum: biochemical characterization of the cysteine protease falcipain-2'. , 2006, Experimental parasitology.
[3] R. Read. Improved Fourier Coefficients for Maps Using Phases from Partial Structures with Errors , 1986 .
[4] P. Rosenthal,et al. Folding of the Plasmodium falciparum Cysteine Protease Falcipain-2 Is Mediated by a Chaperone-like Peptide and Not the Prodomain* , 2002, The Journal of Biological Chemistry.
[5] P. Rosenthal,et al. Antimalarial effects in mice of orally administered peptidyl cysteine protease inhibitors. , 1999, Bioorganic & medicinal chemistry.
[6] Michael G. Rossmann,et al. An Algorithm for Automatic Indexing of Oscillation Images using Fourier Analysis , 1997 .
[7] C. Hoogland,et al. In The Proteomics Protocols Handbook , 2005 .
[8] J F Gibrat,et al. Surprising similarities in structure comparison. , 1996, Current opinion in structural biology.
[9] Randy J Read,et al. Electronic Reprint Biological Crystallography Likelihood-enhanced Fast Rotation Functions Biological Crystallography Likelihood-enhanced Fast Rotation Functions , 2003 .
[10] David S Hartsough,et al. Development of alpha-keto-based inhibitors of cruzain, a cysteine protease implicated in Chagas disease. , 2005, Bioorganic & medicinal chemistry.
[11] Kevin Cowtan,et al. research papers Acta Crystallographica Section D Biological , 2005 .
[12] P. Rosenthal,et al. The Plasmodium falciparum cysteine protease falcipain-2 captures its substrate, hemoglobin, via a unique motif. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[13] A. Chishti,et al. Plasmodium falciparum cysteine protease falcipain-2 cleaves erythrocyte membrane skeletal proteins at late stages of parasite development. , 2002, Blood.
[14] Oliver Zerbe,et al. Structure–Activity Studies in a Family of β‐Hairpin Protein Epitope Mimetic Inhibitors of the p53–HDM2 Protein–Protein Interaction , 2006 .
[15] D. Turk,et al. Crystal structure of cathepsin X: a flip-flop of the ring of His23 allows carboxy-monopeptidase and carboxy-dipeptidase activity of the protease. , 2000, Structure.
[16] P. Rosenthal,et al. Independent Intramolecular Mediators of Folding, Activity, and Inhibition for the Plasmodium falciparum Cysteine Protease Falcipain-2* , 2004, Journal of Biological Chemistry.
[17] S. Müller. Redox and antioxidant systems of the malaria parasite Plasmodium falciparum , 2004, Molecular microbiology.
[18] B. O'connor,et al. Proline specific peptidases. , 1997, Biochimica et biophysica acta.
[19] P. Rosenthal,et al. A malarial cysteine proteinase is necessary for hemoglobin degradation by Plasmodium falciparum. , 1988, The Journal of clinical investigation.
[20] Thomas C Terwilliger,et al. Using prime-and-switch phasing to reduce model bias in molecular replacement. , 2004, Acta crystallographica. Section D, Biological crystallography.
[21] Robert Huber,et al. The refined 2.15 A X‐ray crystal structure of human liver cathepsin B: the structural basis for its specificity. , 1991, The EMBO journal.
[22] D. Goldberg,et al. Food vacuole plasmepsins are processed at a conserved site by an acidic convertase activity in Plasmodium falciparum. , 2003, Molecular and biochemical parasitology.
[23] J. Thompson,et al. The CLUSTAL_X windows interface: flexible strategies for multiple sequence alignment aided by quality analysis tools. , 1997, Nucleic acids research.
[24] I. G. Kamphuis,et al. Structure of papain refined at 1.65 A resolution. , 1984, Journal of molecular biology.
[25] D. Brömme,et al. Human and parasitic papain-like cysteine proteases: their role in physiology and pathology and recent developments in inhibitor design. , 2002, Chemical reviews.
[26] R J Fletterick,et al. A target within the target: probing cruzain's P1' site to define structural determinants for the Chagas' disease protease. , 2000, Structure.
[27] M. Bogyo,et al. Targeted disruption of Plasmodium falciparum cysteine protease, falcipain 1, reduces oocyst production, not erythrocytic stage growth , 2004, Molecular microbiology.
[28] P. Rosenthal,et al. Identification of three stage-specific proteinases of Plasmodium falciparum , 1987, The Journal of experimental medicine.
[29] J T Palmer,et al. Antimalarial effects of peptide inhibitors of a Plasmodium falciparum cysteine proteinase. , 1991, The Journal of clinical investigation.
[30] W. Delano. The PyMOL Molecular Graphics System , 2002 .
[31] P. Evans,et al. Scaling and assessment of data quality. , 2006, Acta crystallographica. Section D, Biological crystallography.
[32] L. Goh,et al. Homology modeling and mutagenesis analyses of Plasmodium falciparum falcipain 2A: implications for rational drug design. , 2004, Biochemical and biophysical research communications.
[33] T. Ramya,et al. Plasmepsin inhibitors: design, synthesis, inhibitory studies and crystal structure analysis. , 2005, The journal of peptide research : official journal of the American Peptide Society.
[34] R J Fletterick,et al. The crystal structure of cruzain: a therapeutic target for Chagas' disease. , 1995, Journal of molecular biology.
[35] D. Goldberg,et al. Plasmodium falciparum falcilysin: an unprocessed food vacuole enzyme. , 2003, Molecular and biochemical parasitology.
[36] L. Goh,et al. Characterization of amino acid variation at strategic positions in parasite and human proteases for selective inhibition of falcipains in Plasmodium falciparum. , 2005, Biochemical and biophysical research communications.
[37] M. Leippe,et al. Synthesis and antiplasmodial activity of a cysteine protease-inhibiting biotinylated aziridine-2,3-dicarboxylate , 2004, Biological chemistry.
[38] P. Rosenthal,et al. Comparison of Efficacies of Cysteine Protease Inhibitors against Five Strains of Plasmodium falciparum , 2001, Antimicrobial Agents and Chemotherapy.
[39] Weltgesundheitsorganisation. World malaria report , 2005 .
[40] Collaborative Computational,et al. The CCP4 suite: programs for protein crystallography. , 1994, Acta crystallographica. Section D, Biological crystallography.
[41] R. Huber,et al. The 2.0 A crystal structure and substrate specificity of the KDEL-tailed cysteine endopeptidase functioning in programmed cell death of Ricinus communis endosperm. , 2004, Journal of molecular biology.
[42] Matthew Bogyo,et al. A Role for the Protease Falcipain 1 in Host Cell Invasion by the Human Malaria Parasite , 2002, Science.
[43] R. Pickersgill,et al. Structure of Monoclinic Papain at 1.60 Angstroms Resolution , 1994 .
[44] R. Pickersgill,et al. Structure of monoclinic papain at 1.60 Å resolution , 1992 .
[45] Ashutosh Kumar Singh,et al. Expression and characterization of the Plasmodium falciparum haemoglobinase falcipain-3. , 2001, The Biochemical journal.
[46] A. Chishti,et al. Ankyrin Peptide Blocks Falcipain-2-mediated Malaria Parasite Release from Red Blood Cells* , 2003, Journal of Biological Chemistry.
[47] Anne Robert,et al. From classical antimalarial drugs to new compounds based on the mechanism of action of artemisinin , 2001 .
[48] J. Baird,et al. Effectiveness of antimalarial drugs. , 2005, The New England journal of medicine.
[49] Ashutosh Kumar Singh,et al. Characterization of Native and Recombinant Falcipain-2, a Principal Trophozoite Cysteine Protease and Essential Hemoglobinase ofPlasmodium falciparum * , 2000, The Journal of Biological Chemistry.
[50] Prashant Desai,et al. Homology Modeling of Falcipain-2: Validation, De Novo Ligand Design and Synthesis of Novel Inhibitors , 2002, Journal of biomolecular structure & dynamics.
[51] Eric Legrand,et al. Resistance of Plasmodium falciparum field isolates to in-vitro artemether and point mutations of the SERCA-type PfATPase6 , 2005, The Lancet.
[52] R. Stocker,et al. Oxidative stress and protective mechanisms in erythrocytes in relation to Plasmodium vinckei load. , 1985, Proceedings of the National Academy of Sciences of the United States of America.
[53] Khashayar Karimian,et al. Thiol proteases: inhibitors and potential therapeutic targets. , 2006, Current medicinal chemistry.
[54] Adam Godzik,et al. The importance of alignment accuracy for molecular replacement. , 2004, Acta crystallographica. Section D, Biological crystallography.
[55] Purnomo,et al. Short report: therapeutic efficacy of chloroquine combined with primaquine against Plasmodium falciparum in northeastern Papua, Indonesia. , 2002, The American journal of tropical medicine and hygiene.
[56] D. Goldberg,et al. Plasmodium falciparum Falcilysin , 2003, Journal of Biological Chemistry.
[57] P. Rosenthal,et al. Antimalarial Synergy of Cysteine and Aspartic Protease Inhibitors , 1998, Antimicrobial Agents and Chemotherapy.
[58] R J Read,et al. Crystallography & NMR system: A new software suite for macromolecular structure determination. , 1998, Acta crystallographica. Section D, Biological crystallography.
[59] K. Haldar,et al. In Vitro Activity of Riboflavin against the Human Malaria Parasite Plasmodium falciparum , 2000, Antimicrobial Agents and Chemotherapy.
[60] R J Fletterick,et al. Structural determinants of specificity in the cysteine protease cruzain , 1997, Protein science : a publication of the Protein Society.
[61] S. Hoffman,et al. Primaquine therapy for malaria. , 2004, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[62] R E Cachau,et al. Structure and inhibition of plasmepsin II, a hemoglobin-degrading enzyme from Plasmodium falciparum. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[63] N. Rawlings,et al. Evolutionary Lines of Cysteine Peptidases , 2001, Biological chemistry.
[64] J. Thornton,et al. Stereochemical quality of protein structure coordinates , 1992, Proteins.
[65] D. Goldberg,et al. Biosynthesis and Maturation of the Malaria Aspartic Hemoglobinases Plasmepsins I and II* , 1997, The Journal of Biological Chemistry.
[66] A G Leslie,et al. Biological Crystallography Integration of Macromolecular Diffraction Data , 2022 .
[67] L. Brinen,et al. Crystal structures of reversible ketone-Based inhibitors of the cysteine protease cruzain. , 2003, Bioorganic & medicinal chemistry.
[68] S Muller. The redox and antioxidant systems of Plasmodium falciparum , 2004 .
[69] P. Rosenthal,et al. Systematic optimization of expression and refolding of the Plasmodium falciparum cysteine protease falcipain-2. , 2001, Protein expression and purification.
[70] P. Rosenthal,et al. Gene disruption confirms a critical role for the cysteine protease falcipain-2 in hemoglobin hydrolysis by Plasmodium falciparum. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[71] J. Frangos,et al. Plasmodium berghei Resists Killing by Reactive Oxygen Species , 2005, Infection and Immunity.
[72] P. Rosenthal,et al. Biosynthesis, localization, and processing of falcipain cysteine proteases of Plasmodium falciparum. , 2005, Molecular and biochemical parasitology.